Circulating tumor DNA–defined minimal residual disease in solid tumors: Opportunities to accelerate the development of adjuvant therapies

Arvind Dasari, Axel Grothey, Scott Kopetz

Research output: Contribution to journal › Comment/debate › peer-review

24 Scopus citations

Fingerprint

Dive into the research topics of 'Circulating tumor DNA–defined minimal residual disease in solid tumors: Opportunities to accelerate the development of adjuvant therapies'. Together they form a unique fingerprint.